Skye Bioscience, Inc. (SKYE)

NCM – Real Time Price. Currency in USD

0.55

+0.00 (0.76%)

Market open: Aug 12, 2026, 12:59 PM EDT

0.55

+0.01 (1.68%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-723K

-299K

-124K

-115K

Gross Profit

-723K

-299K

-124K

-115K

Operating expenses (excl. COGS)

-57M

-36M

-14M

-12M

Operating Income

-58M

-36M

-14M

-12M

Non-operating income, total

10M

-24M

-7M

Pretax income

-56M

-27M

-38M

-19M

Equity in earnings

Taxes

-5K

-10K

-4K

-7K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-56M

-27M

-38M

-19M

Discontinued operations

Net income

-56M

-27M

-38M

-19M

Dilution adjustment

Preferred dividends

Skye Bioscience, Inc. (SKYE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Skye Bioscience, Inc. (SKYE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Skye Bioscience, Inc. (SKYE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Skye Bioscience, Inc. (SKYE)

Income Statement (Annual)

Income Statement (Annual)